Revlimid® Capsules General Drug Use-results Surveillance (Relapsed or Refractory FL and MZL)

Clinical trial NCT04618081 · COMPLETED

Trial details

NCT number: NCT04618081
Sponsor: Celgene
Status: COMPLETED
Study type: OBSERVATIONAL

Lymphoma Nonhodgkin

Start date: 2020-12-17
Primary completion: 2025-03-27
Enrollment: 151

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.